Galvin, Gaustad & Stein, LLC Amgen Inc Transaction History

Galvin, Gaustad & Stein, LLC

  • $1.06 Billion
  • Q3 2024

A detailed history of Galvin, Gaustad & Stein, LLC transactions in Amgen Inc stock. As of the latest transaction made, Galvin, Gaustad & Stein, LLC holds 1,908 shares of AMGN stock, worth $553,129. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,908
Previous 2,032 6.1%
Holding current value
$553,129
Previous $634,000 3.15%
% of portfolio
0.06%
Previous 0.06%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024
SELL
$309.38 - $337.38 $38,363 - $41,835
-124 Reduced 6.1%
1,908 $614,000
Q2 2024

Jul 17, 2024
SELL
$262.75 - $319.31 $30,216 - $36,720
-115 Reduced 5.36%
2,032 $634,000
Q1 2024

Apr 15, 2024
SELL
$268.87 - $324.56 $154,600 - $186,622
-575 Reduced 21.12%
2,147 $610,000
Q4 2023

Jan 11, 2024
SELL
$255.7 - $288.46 $259,791 - $293,075
-1,016 Reduced 27.18%
2,722 $783,000
Q3 2023

Oct 18, 2023
SELL
$218.65 - $271.46 $3.78 Million - $4.69 Million
-17,285 Reduced 82.22%
3,738 $1 Million
Q2 2023

Jul 24, 2023
BUY
$214.27 - $253.37 $1.01 Million - $1.2 Million
4,730 Added 29.03%
21,023 $4.67 Million
Q1 2023

Apr 17, 2023
BUY
$225.79 - $275.2 $3.26 Million - $3.97 Million
14,440 Added 779.28%
16,293 $3.94 Million
Q4 2022

Feb 13, 2023
SELL
$229.03 - $291.01 $4.79 Million - $6.09 Million
-20,910 Reduced 91.86%
1,853 $486,000
Q3 2022

Oct 26, 2022
SELL
$224.46 - $253.15 $619,509 - $698,694
-2,760 Reduced 10.81%
22,763 $5.13 Million
Q2 2022

Jul 22, 2022
SELL
$230.71 - $256.74 $1.79 Million - $2 Million
-7,777 Reduced 23.35%
25,523 $6.21 Million
Q1 2022

Apr 27, 2022
BUY
$219.27 - $242.57 $635,883 - $703,453
2,900 Added 9.54%
33,300 $8.05 Million
Q4 2021

Jan 31, 2022
BUY
$198.88 - $227.6 $623,687 - $713,753
3,136 Added 11.5%
30,400 $6.84 Million
Q3 2021

Oct 29, 2021
BUY
$212.27 - $248.7 $5.12 Million - $6 Million
24,125 Added 768.56%
27,264 $5.8 Million
Q2 2021

Jul 29, 2021
SELL
$233.58 - $259.14 $6,306 - $6,996
-27 Reduced 0.85%
3,139 $765,000
Q1 2021

Apr 19, 2021
BUY
$221.91 - $258.6 $4,660 - $5,430
21 Added 0.67%
3,166 $788,000
Q4 2020

Feb 04, 2021
BUY
$216.38 - $257.67 $680,515 - $810,372
3,145 New
3,145 $723,000

Others Institutions Holding AMGN

# of Institutions
3,122
Shares Held
410M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $155B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Galvin, Gaustad & Stein, LLC Portfolio

Follow Galvin, Gaustad & Stein, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Galvin, Gaustad & Stein, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Galvin, Gaustad & Stein, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email